Evidence mapPaperPMID 40650198Full record

ReviewInternational journal of molecular sciences2025

Monocyte Involvement in the Pathogenesis of Myeloproliferative Neoplasms.

Xuedong Li, Mingli Xu, Yingying Wang

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Xuedong LiDepartment of Immunology, School of Basic Medical Sciences, Chongqing Medical University, Chongqing 400016, China.
Mingli XuDepartment of Immunology, School of Basic Medical Sciences, Chongqing Medical University, Chongqing 400016, China.
Yingying WangDepartment of Immunology, School of Basic Medical Sciences, Chongqing Medical University, Chongqing 400016, China.ORCID 0000-0002-3923-8206

Funding

National Natural Science Foundation of China 82000135
6 · The paper itself

Abstract

Classical BCR-ABL-negative myeloproliferative neoplasms are a heterogeneous group of hematologic malignancies, including essential thrombocythemia, polycythemia vera, and primary myelofibrosis. Monocytes, immune cells derived from hematopoietic stem cells, exhibit significant heterogeneity and contribute to immune regulation through cytokine secretion and differentiation into dendritic cells and macrophages. Aberrant monocytes are associated with the prognosis of MPNs, particularly PMF. Furthermore, these altered monocytes play a critical role in the pathogenesis and progression of MPNs. This review aims to explore the heterogeneity of different monocyte subsets during homeostasis and focuses on the potential mechanisms by which monocytes contribute to the development and progression of MPNs.

Indexed as

Bone Marrow NeoplasmsMyeloproliferative DisordersAnimalsCell DifferentiationCytokinesDisease ProgressionHomeostasisHumansMonocytesCytokinesmonocytesmyeloproliferative neoplasmsSLAMF7Tie2

Identifiers

PMID40650198
PMCPMC12250554

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.